In human ovarian cancer tissue samples, expression of p-ALK was associated with resistance to PARP inhibitors (Fig. 1c) and platinum-based (cisplatin/carboplatin) chemotherapy (Fig. 1d, left panel). The gene discussed is PARP1; the disease is ovarian cancer.